4/A//SEC Filing
Dearen Danny L. 4/A
Accession 0001562180-23-007189
CIK 0001603756other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 7:32 PM ET
Size
9.4 KB
Accession
0001562180-23-007189
Insider Transaction Report
Form 4/AAmended
Axonics, Inc.AXNX
Dearen Danny L.
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-02-03+36,919→ 57,919 total - Sale
Common Stock
2022-02-03$49.03/sh−947$46,436→ 39,235 total - Sale
Common Stock
2022-02-03$48.21/sh−17,737$855,106→ 40,182 total
Footnotes (4)
- [F1]This amendment is being filed to address an error in reporting the amount of securities beneficially owned following reported transactions on February 3, 2022. Accordingly, this amendment is being filed to amend and restate this line from the Original Form 4 in its entirety. This Form 4 acts as an amendment for all subsequently filed Form 4s.
- [F2]Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein.
- [F3]This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Axonics, Inc.
CIK 0001603756
Entity typeother
Related Parties
1- filerCIK 0001756438
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 7:32 PM ET
- Size
- 9.4 KB